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1. Introduction 
The tripeptide glutathione plays an important role 
within cells, where it is ab~d~~y present in its 
reduced form. Very low levels are found extracellularly 
[l-3]. The role of extracellular glutathione is poorly 
understood. In [4] we suggested the kidney as an 
important organ in the turnover of plasma ~uta~one 
and showed that the rat liver is impermeable to GSH 
or GSSG. Although controversy remains regarding 
the physiological function, a predominant participa- 
tion of the kidney in the turnover of extracellular 
glutathione is established [5-91. Here, we investigated 
the glutathione plasma level in man taking into account 
the implications of a concentration gradient of 
>3 orders of magnitude between erythrocyte and 
plasma. In a single in vivo experiment we determined 
the apparent half-life of glutathione in human plasma 
to be 1 d min. 
2. Experimental 
Blood (10 ml) was drawn into cooled tubes pre- 
coated with 140 IU ammonium heparinate from 
healthy adults and immediately centrifuged at 4’C, 
3000 X g for 8 min. Plasma was recentrifuged at 
8000 X g for 1 min. Protein was immediately precipi- 
tated adding 0.1 vol. icecold 300 g/l metaphosphoric 
acid containing lmrnol/l ethylendiamine t traacetic 
acid. 
Sterile, pyrogen-free GSH, 100 mg (Robin, SPA, 
Milano) was dissolved in 1 ml sterile sodium bicar- 
bonate solution to yield a final pH of 7.1 and dis- 
solved to 10 ml with isotonic saline. The solution was 
injected within 10 s into the right vein of one of the 
authors (A. W., male, age 36 years, 64 kg body wt). 
Blood samples (10 ml) were withdrawn at the left 
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arm vein within 20 s, transferred to an ice bath and 
treated as above after the experiment’s end. Creatinine 
clearance was determined within the following 24 h 
interval. 
Total glutathione concentrations were measured 
by the kinetic assay using the glutathione reductase 
reaction essentially as in [lo]. The results are given 
in GSH equivalents (GSH + 2 GSSG). GSSG was 
measured by determining the end-point of the gluta- 
thione reductase reaction [ 111. 
To assess the extent of hemolysis, whole blood 
hemo~ob~ was measured by a modified Drabkin 
procedure [121. The very low plasma hemoglobin 
concentrations were determined by difference dual 
wavelength spectrophotometry of carbonmonoxy- 
ferrohemo~ob~ under the following conditions: a 
baseline was run at the wavelength couple 418-424.5 
nm in 0.1 mol/l potassium phosphate buffer (pH 7.0); 
after addition of sodium dithionite (fmal cont. 2 mM) 
the cuvette was bubbled with CO for 20 sand another 
spectrum was run. In a&samples hemolysis was 
<0.03%. r-Glutamyltranspeptidase was determined 
according to [ 131. 
3. Results and discussion 
The mean total glutathione content in the plasma 
of 11 male and 9 female adults was found to be 
0.34 rt 0.11 ctmol/l. GSSG was GO.1 @mol/l in 12 sub- 
jects and O.l-O.28cunol/l in 8 subjects. No sex-related 
differences were observed. We also determined total 
plasma glutathione of a bilaterally nephrectomized 
female patient and found a level of 0.53 iumol/l. Thus 
the concentration gradient between intrae~~rocytic 
and plasma glutathione amounts nearly to 4 orders of 
magnitude. Two possible interferences had to be 
ruled out: (i) a minute hemolysis, be it endogenous or
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during blood sampling, may account for the amount 
of glutathione found; (ii) a varying activity of plasma 
~-~ut~yltr~peptida~ may substantially degrade 
the glutathione present. The mean plasma hemo~ob~ 
concentration was 1.47 + 1.02 mg/lOO ml plasma nd 
the correlation between hemoglobin and plasma glu- 
tathione concentration was y = 0.01. r-Glutamyltrans- 
peptidase activity amounted to 8.5 + 2.6 U/l and cor- 
related with the plasma glutathione concentration 
with r = 0.001. This means that neither of these two 
parameters showed any correlation with the amount 
of glutathione determined and might have influenced 
the result obtained for plasma glutathione. That the 
value found here is considerably ower than the data 
in f l -3]may be due to the controlled m~m~tion 
of hemolysis [141 in our study. For laboratory ani- 
mals, also much higher plasma glutathione l vels were 
reported, e.g., 18-60 pmol/l for mice [ 151 and 
3 mol/l for rats [7,16]. 
In a single self-experiment we investigated the fate 
of intravenously injected glutathione in man. Fig.1 
I . I * 1 
0 2 5 [minIlO 15 
Fig.1. In vivo elimination of a single dose of 1.56 mg gluta- 
thione/kg (total 100 mg) from human plasma: (=) total gluta- 
thione; (o) oxidized glu~~ione. 
shows that a single dose of 100 mg GSH is rapidly 
eliminated from plasma. We observe adistribution 
phase within the first 2 min and a clearance in the fol- 
lowing 10 min. From the se~og~ith~ca~y plotted 
clearance phase an apparent half-life of 1.6 min is cal- 
culated. Extrapolation of this straight line to zero time 
shows that the tripeptide distributed completely into 
the extracellular space: if we assess the interstitial 
plus plasma volume with 21% of the subjects body 
weight (= 13 liters) we expected without clearance an 
equilibrium concentration of 25 wolfi. It seems that 
a considerable proportion of the administered gluta- 
thione has been oxidized to GSSG, although we can- 
not exclude that this GSSG might have been released 
from the ~trace~ular space. Using the borohyd~de 
reduction method [ 171, no mixed-disulfides could 
be detected. In vitro controls with the subject’s whole 
blood or plasma indicated that neither GSH or GSSG 
are si~i~c~tly metabolized within 20 min at 25 
~mol/l. 
The subject’s creatinine clearance was 136 ml/mm 
i.e., if glutathione is cleared from the glomerular fil- 
trate as effectively as creatinine, ahalf-life of 15 min 
is expected. Thus renal intratubular degradation alone 
does not account for the total plasma glutathione 
turnover. With a total renal plasma flow of 680 ml/mm, 
the half-life would be 2.6 min. Even if we assume a
complete ‘extraction’ of glutathione during one pas- 
sage of the kidneys [ 181, still -50% of the observed 
free plasma glutathione turnover must occur extra- 
renally. This view is subst~ti~y supported in [7] 
where, in the anaesthetized rat, a 50% renal gluta- 
thione turnover capacity was calculated. Whether the 
contribution of the extrarenal glutathione turnover is 
due to uptake or to degradation by other organs 
remains open. 
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